Evidence map›Paper›PMID 38628666›Full record

ArticleFrontiers in oncology2024

Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis.

Yi-Nan Li, Shao-Ming Wei, Yang-Kai Fu, Zhen-Xin Zeng, Li-Ming Huang, Jia-Hui Lv, Wei-Zhao Chen, Yong-Gang Wei, Zhi-Bo Zhang, Jian-Yin Zhou and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi-Nan Li *Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Shao-Ming Wei *Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Yang-Kai FuShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Zhen-Xin ZengShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Li-Ming HuangShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Jia-Hui LvShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Wei-Zhao ChenShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Yong-Gang WeiDepartment of Liver Surgery, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Zhi-Bo ZhangDepartment of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Jian-Yin ZhouDepartment of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian, China.
Jia-Yi WuShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Mao-Lin YanShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Portal vein tumor thrombus (PVTT) seriously affects the prognosis of hepatocellular carcinoma (HCC). However, whether bile duct tumor thrombus (BDTT) significantly affects the prognosis of HCC as much as PVTT remains unclear. We aimed to compare the long-term surgical outcomes of HCC with macroscopic PVTT (macro-PVTT) and macroscopic BDTT (macro-BDTT). Methods: The data of HCC patients with macro-BDTT or macro-PVTT who underwent hemihepatectomy were retrospectively reviewed. A propensity score matching (PSM) analysis was performed to reduce the baseline imbalance. The recurrence-free survival (RFS) and overall survival (OS) rates were compared between the cohorts. Results: Before PSM, the PVTT group had worse RFS and OS rates than the BDTT group (P = 0.043 and P = 0.008, respectively). Multivariate analyses identified PVTT (hazard ratio [HR] = 1.835, P = 0.016) and large HCC (HR = 1.553, P = 0.039) as independent risk factors for poor OS and RFS, respectively. After PSM, the PVTT group had worse RFS and OS rates than the BDTT group (P = 0.037 and P = 0.004, respectively). The 3- and 5-year OS rates were significantly higher in the BDTT group (59.5% and 52.1%, respectively) than in the PVTT group (33.3% and 20.2%, respectively). Conclusion: Aggressive hemihepatectomy provides an acceptable prognosis for HCC patients with macro-BDTT. Furthermore, the long-term surgical outcomes of HCC patients with macro-BDTT were significantly better than those of HCC patients with macro-PVTT.

Indexed as

hepatocellular carcinomamacroscopic bile duct tumor thrombusmacroscopic portal vein tumor thrombusoverall survivalpropensity score matching analysis

Identifiers

PMID38628666
PMCPMC11018934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.